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Introduction 
Extremely low-frequency electromagnetic fields (ELF-
EMFs) have been developed in laboratories for many 
years. Exposure to ELF-EMF can affect many cellular 
structures and compounds, such as the deoxyribonucleic 
acid in the nucleus, cell reproduction, mechanism of cell 
death through the cell cycle, metabolism, and the vast 
majority of protein malfunction.1 The outcome of a study 
focused on oxidative stress of global cerebral ischemia, 
and reactive oxygen species, demonstrate the possibility 
of reduction of adverse consequences if ELF-EMF 
established.2
Recent studies suggest that primary rehabilitation 
therapy by ELF-EMF may be helpful in post-stroke 
patients.3 This method of laser therapy can affect any 
organism at any level, such as cellular, subcellular, and 
molecular.4,5 This therapy can modify the neural damage 
caused by the huge levels of oxidative stress. However, its 
effectiveness has not been utterly evaluated.6,7 The neural 
damage after a brain stroke causes a drastic reduction in 
the functional situation and cognitive impairment.8
It has been found that low-level laser therapy (LLLT) can 
accentuate the vast majority of biological manners, such as 
rise in adenosine triphosphate synthesis in mitochondrial 
respiration, angiogenesis, facilitating wound healing and 
regeneration in skeletal muscle.9 According to the previous 
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Abstract
Introduction: Stroke is one of the most devastating neurologic conditions in the world. Despite all 
the efforts that have been made for effective treatment, the prevalence of this medical condition 
is still high. One of the new methods in the treatment of patients is the use of low power laser 
and pulsed magnetic fields. The previous studies investigated the effectiveness of these methods 
individually. However, the present study aimed to investigate their effectiveness in combination.
Methods: We divided the patients into control (n = 26) and experimental (n=26) groups. The primary 
variables included the Mini-Mental State Examination (MMSE) and the National Institute of Health 
Stroke Scale (NIHSS). The experimental group received extremely low-frequency electromagnetic 
field (EMF-ELF) treatment with 1 mT power and laser in rejection with a wavelength of 840 nm for 
5 days and 45 min/d.
Results: The variable measured during this study, in addition to comparing the results of the 
intervention between the control and experimental groups, showed a significant difference in all 
indicators before and after the intervention. The mean and standard deviations of the modified 
Rankin scale (mRS), functional status (Barthel’s index), and cognitive status (MMSE) (P < 0.001) were 
signed between 2 groups.
Conclusion: Laser and magnetic field combination can be effective in the treatment of stroke. Further 
studies are recommended to ensure a better comparison.




Department of Neurology, 
Shohada-e-Tajrish Hospital, 
Shahid Beheshti University of 
Medical Sciences, Tehran, Iran.
Email: Amir1939@gmail.com
Published online June 21, 2020
Int Clin Neurosci J. 2020 Summer;7(3):127-131                                              Original Article
International Clinical
Neuroscience Journal
© 2020 The Author(s). This is an open access article distributed under the terms of the Creative Commons Attribution License (http://
creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided the original 
work is properly cited.
doi:10.34172/icnj.2020.13
Citation: Farzad Ashrafi F, Rezaei A, Azhideh A, Tabeie F, Gachkar L, Arab-Ahmadi M, Yousefi-Asl M, Zali A.Effectiveness of Extremely 
Low Frequency Electromagnetic Field and Pulsed Low-Level Laser Therapy in Acute Stroke Treatment. Clin Neurosci J. 2020;7(3):127-
131. doi:10.34172/icnj.2020.13.
Open Access
Scan to access more
free content
Ashrafi et al
Int Clin Neurosci J. Vol 7, No 3, Summer 2020128 journals.sbmu.ac.ir/Neurosciencehttp
studies, 50% to 70% of the reduction was in infarct size 4 
to 6 weeks after coronary artery chronic obstruction in 
the use of LLLT in an experiential model of the infarcted 
heart.10,11 Although there is limited research about the 
effects of LLLT on stroke, it unveiled its improvements in 
nervous system processes. 
This study aimed to investigate the effect of ELF-EMF 
and LLLT in combination with post-stroke patients.
Methods
Patients
The present study first examined all the patients with 
acute stroke who were admitted to Shohada Hospital 
Neurology Ward, Tehran from May 2018 to December 
2018. Among these patients, only 52 ones were eligible 
for the study. Those who did not receive thrombolytic 
therapy, aged over 18 years, had the first stroke involving 
only one hemisphere, had symptoms over the last 48 
hours, patients with NIHSS (National Institute Of Health 
Stroke Scale) > 4, and those who had steady clinical 
awareness and ability to perform simple voice commands 
were included in the study.12 The exclusion criteria 
included patients with acute cerebral bleeding, previous 
history of ischemic and hemorrhagic stroke, history of 
seizure, lacunar infarction, mRS history> 1, metal tools 
inside the body (e.g. cardiac pacemaker), life expectancy 
less than 3 months, another serious illness that interferes 
with this treatment and lactating or pregnant women or 
positive pregnancy test.13 
Study Design
This study was designed as a single-blind randomized 
clinical trial. According to a computer-generated 
randomization schema, the eligible 52 patients were 
randomly assigned into 2 groups: Treatment (n=26) and 
control group (n=26). All patients received standard 
therapy in both groups, but in the treatment group, they 
received additional therapy with LLLT method. All of the 
patients in both groups were informed about the clinical 
trial and asked to fill the consent form.
Patients were under clinical and radiological 
examinations48 hours after the onset of stroke symptoms. 
Then, after assessing patients for inclusion criteria, they 
were qualified to enter the study. The treatment was 
initiated with EMF-ELF at 1 mT 50 Hz for 5 days per day 
from 45 minutes each day and an infrared laser with a 
wavelength of 840 nm and 12 watts at 12 different points, 
similar to the 10-20 electroencephalography system. All 
of the patients were monitored closely in both groups. 
The stimulus was discontinued in the treatment group in 
case of any side effects. Rehabilitation and routine stroke 
treatments were performed jointly in both groups.
The NIHSS system consists of 11 axes, each axis can 
score from zero to 2, 3 or 4 points depends on the axis. 
Maximum 42 and minimum 0 points are possible. A 
point below 5 can account for the absence or minor stroke 
symptoms. The points above 5 are divided into three-
stroke groups: moderate (5-15), moderate to severe (20-
16), and severe (21-42).14
Modified Rankin scale (mRS) measures the severity 
of the inability to perform daily activities in people with 
a stroke or other neurological defects. This criterion 
can vary from zero (asymptomatic) to six (death).13 
Depression was used in both groups using the Geriatric 
Depression Scale (GDS). This scale was a 30-item 
questionnaire completed by each individual. It is 
divided into three groups: normal (0-9 points), mild 
depression (19-19 points), and severe depression (20-
30).15 The patient’s cognitive status is calculated on the 
basis of MMSE, which includes 6 areas of orientation, 
registration, attention, language, recall, and calculation. 
The maximum score is 30. Points below 24 (19-23) 
indicate mild intermediate (19-10) and severe (less than 
9) cognitive impairment.16
Patients were also evaluated for their functional status 
via the Barthel index for daily living activities. This 
criterion reflects the level of person’s freedom to perform 
simple and complex activities, as well as the gait of 
patients.13
NIHSS, GDS, MMSE, BI, and side effects were studied, 
45 days after the onset of the disease at an outpatient visit 
in hospital affiliated clinic.
Statistical Analysis
Data were analyzed via SPSS 16.0 (IBM Crop., Armonk, 
USA) to compare the qualitative data in two groups, chi-
square test or Fisher exact test and quantitative data with 
independent distribution of t test and normal distribution. 
Otherwise, the Mann-Whitney test was used. To compare 
the quantitative data in each group, before and after the 
intervention, if a normal distribution was used, the paired 
t test was used and otherwise Wilcoxon test was used. In 
all cases, the significance limit was placed on P < 0.05.
Results 
In this study, 52 patients with acute stroke were studied in 
2 groups of 26 patients receiving laser and magnetic field 
and the control group. In cases 17 (65.4%) and 9 (34.6%) 
were male and female respectively versus 10 (38.5%) male 
and 16 (61.5%) female in controls. The difference between 
groups was not significant (P = 0.09). The demographic 
characteristics of patients in the two groups are presented 
in Table 1. Based on the Kolmogorov-Smirnov test, 
all quantitative variables followed normal distribution 
before and after the intervention except for mRS before 
the intervention and in the control group (Table 2). 
The mean age ± standard deviation in the experimental 
group was 63.5 ± 14.3 years and in the control group 
was 65.9 ± 15.7 years, the mean and standard deviation 
of body mass index (BMI) in the experimental group 
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was 30.2 ± 2.7 kg/m2 and in the control group 31.2 ± 3.8 
kg/m2 and the difference between the groups were not 
significant. The distribution of the 2 groups for the 
underlying and intervention variables is shown in Table 
2 (P = 0.57, P = 0.26). The difference between the 2 groups 
was not statistically significant in any cases. In other 
words, the 2 groups were similar in terms of underlying 
and confounding variables (Table 2).
Using independent t test and Mann-Whitney, the 
difference between 2 groups was not significant for any of 
the dependent variables before the intervention. In other 
words, the 2 groups were matched for the dependent 
variables before the intervention. The independent 
t test showed that the difference between 2 groups 
was significant for Barthel’s index (P < 0.006), GDS 
(P < 0.001), MMSE (P < 0.035). The Mann-Whitney test 
showed that the difference between the 2 groups was the 
significance mRS after intervention (P < 0.001). In the 
experimental group, 1 patient began to have a headache 
(3.8%) and 3 patients (11.5%) experienced an unpleasant 
warmth, while there were no relevant side effects in the 
control group. After the intervention, the antidepressant 
treatment was necessary for 6 patients (23.1%).
In stimulation group and for 8 patients (30.8%) in 
the control group. From this point of view, there are 
also significant differences between 2 groups (P = 0.76). 
The paired t test in the control group showed that the 
differences between NIHSS, Barthel’s Index, GDS, MMSE 
variables in the control group were significant before and 
after the treatment (in all cases P < 0.001). Additionally, 
Wilcoxon test showed that the difference in mRS before 
and after the intervention was significant in this group 
(P < 0.001). By paired t test, the difference in NIHSS, 
Barthel’s Index, GDS, MMSE before and after intervention 
was significant (in all cases P < 0.001) and Wilcoxon test 
showed that there was a drastic difference in mRS before 
and after the intervention (P < 0.001) (Table 3).
Discussion 
Since the onset of stroke, the muscular neural function 
Table 2. Distribution of Acute Stroke Patients Receiving Laser Along the Magnetic Field and Their Control Group in Terms of Underlying Variables and 
Interfering With the Result of the Kolmogorov-Smirnov Test
Variables Controls P Value Cases P Value
BMI, kg/m2 31.2 ± 3.8 0.41 30.2 ± 2.7 0.79
NIHSS before, kg/m2 8.5 ± 3.3 0.38 8.4 ± 3.3 0.86
NIHSS after, kg/m2 7.2 ± 3.1 0.58 5.9 ± 3.3 0.58
BARTHEL before, Kg/m2 9.4 ± 2 0.58 10.1 ± 2.5 0.45
BARTHEL after, kg/m2 13.3 ± 2.2 0.49 15 ± 2.2 0.68
mRS before, kg/m2 2.6 ± 0.8 < 0.01 2.7 ± 2.7 0.05
mRS after, kg/m2 2.5 ± 0.6 < 0.01 1.6 ± 0.8 0.07
GDS before, kg/m2 11.3 ± 2.5 0.49 12 ± 2.2 0.92
GDS after, kg/m2 9.1 ± 2.4 0.43 6.4 ± 2.2 0.58
MMSE after, kg/m2 23 ± 2.3 0.45 23.1 ± 2.1 0.75
MMSE before, kg/m2 24.1 ± 1.9 0.31 25.3 ± 2.2 0.25
BMI: body mass index; NIHSS: National Institute of Health Stroke Scale; mRS: modified Rankin scale; GDS; geriatric depression scale; MMSE; mini-mental 
state examination.
Table 1. The demographic characteristics of patients among cases and control groups 
Variable Case Control P Value
Hypertension 21 (80.8%) 22 (84.6%) 1
Hyperlipidemia 15 (57.7%) 14 (53.8%) 1
Diabetes 7 (26.9%) 9 (34.6%) 0.76
Smoking 10 (38.5%) 13 (50%) 0.58
Anti-platelets 16 (61.5%) 17 (65.4%) 1
Antidepressant before intervention 6 (23.1%) 4 (15.4%) 0.73
Origin   0.16
Right anterior 8(30.8%) 9(34.6%)  
Right posterior 6(23.1%) 1(4%)  
Left anterior 7(26.9%) 13(50%)  
Lateral posterior 5(19.2%) 3(11.5%)  
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has been associated with cognitive impairment and 
cognitive impairment, problem-solving skills, memory 
impairment, incomprehensible thinking, and speech 
impairment. It also includes mental illness, depression, 
anxiety, emotional instability, and fatigue.17 Inpatient 
physical therapy can greatly reduce post-stroke weakness 
when established in immediate admission.
Despite the uncertain effects of ELF-EMF, it may 
produce biological effects, including alterations in ion 
equilibrium which leads to the uncompensated magnetic 
spin of free radicals, paramagnetic elements, diamagnetic 
molecule, and also magnetostrictive and piezoelectric 
feature in tissue structure.18 The main parts of cells and 
tissues include water, cholesterol, and its derivatives, 
which form the crystal structure and are affected by the 
electromagnetic field.19,20
In a study on the effect of oxidative stress on 
rigorous neurorehabilitation in post-acute ischemic 
stroke, Ciancarelli et al21 demonstrated that vigorous 
Neurotherapy could decrease oxidative stress and increase 
endogenous antioxidant arrangement, whereby reducing 
neurological deficits. Animal research on rats and 
rabbits showed that transcranial LLLT can improve the 
neurological outcome after embolic stroke up to 24 and 6 
hours, respectively.15 The other animal study showed that 
LLLT did not improve the rabbit’s neurological deficits 
after 24 hours of the stroke.14 The different outcomes 
from various studies might be the result of variety in 
methods of stroke induction. For instance, using filament 
or craniotomy in rats against microbeads injection 
thorough the carotid artery in rabbits. Despite the great 
effort in studying the bio stimulatory outcomes of CW 
mode in LLLT, there was not much investigation in the 
pulsed mode. Moreover, the effect of pulsed mode LLLTs 
on the attenuation of ischemic tissue was not well studied. 
Neurogenesis is a mechanism correlated by the attenuation 
of the behavioral shortages in stroke-induced rats via 
LLLT. Previous studies on laser mechanism indicated 
the correlation of heat shock protein upregulation and 
angiogenic plus antioxidant activity rise, with myogenic 
cell and ischemic heart tissue.9 Additionally, studies 
showed the upregulation of TGF-1 by LLLT in the 
ischemic brain, which has a neuroprotective effect while 
coordinately overcoming NO (nitric oxide) synthase. In 
2014, Hacke et al22 had started NEST-3 trial for the efficacy 
and safety of LLLT on 600 acute stroke patients before 24 
hours of starting symptoms. The follow-up time was 90 
days, but the trial ended due to lack of positive results. So 
in 2018 AHA/ASA23 regarding that trial stated that LLLT 
is not harmful nor effective for acute stroke patients; but 
due to the positive outcome of our trial, combination of 
LLLT and EMF-ELF might be effective for acute stroke 
patients.24
The limitations of this study were a short time of 
stimulation (45 minutes), little follow-up window (45 
days), a single-blinded study (observer bias), and limited 
numbers of patients. Therefore, we suggest further 
investigation in double-blind multicenter trials with 
much more stimulation time (up to 120 minutes daily), 
longer follow-up time (up to 1 year). Also, we suggest 
that the antioxidant effect of this therapy be measured via 
lab tests. Due to the meticulous inclusion criteria, many 
stroke-stricken patients who had severe neurological 
deficits were eliminated which left us with mild to 
moderate deficits. Due to the nature of the study, we could 
not use a placebo or sham. 
In conclusion, the combination of laser and magnetic 
fields can be effective in treating stroke. Further studies 
are recommended to ensure greater reliability and better 
comparison.
Future Directions
Multicenter academic collaboration is a key element to 
improve our knowledge of the effectiveness of EMF-ELF 
and LLLT combined on the treatment of acute stroke. 
EMF-ELF and LLLT are not easily accessible due to the 
Table 3. Variables Difference Before and After Intervention NIHSS: National Institute Of Health 
















NIHSS: National Institute of Health Stroke Scale; mRS: modified Rankin scale; GDS; geriatric depression scale; MMSE; mini-mental state examination.
* Wilcoxon Test
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high cost. In the next few years’ numerous observational 
studies and treatment trials on acute stroke will increase 
the level of evidence that currently supports this treatment.
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